TY - JOUR
T1 - Effective Radiation Therapy for Isolated Apical Pulmonary Amyloidoma
T2 - A Case Report and Treatment Insight
AU - Harmouch, Wissam
AU - Waguespack, Angela
AU - McHenry, James
AU - Mercado, Anita
N1 - Publisher Copyright:
© Am J Case Rep, 2024.
PY - 2024
Y1 - 2024
N2 - Patient: Male, 68-year-old Final Diagnosis: Amyloidoma Symptoms: Shortness of breath linical Procedure: — Specialty: Pulmonology Objective: Background: Case Report: Conclusions: Rare disease Amyloidosis refers to an assortment of diseases characterized by the accumulation and deposition of misfolded proteins in the extracellular matrix of tissues and organs. It may present systemically, affecting multiple organs, or locally by affecting a single organ. When the lungs or mediastinal structures are involved, the term pulmonary amyloid is used. Sole pulmonary involvement with amyloid is extremely rare. There is no definitive treatment for this disease, but proposed treatment options include surgery, cytotoxic medications, and external beam radiation therapy (EBRT). A 68-year-old man with a left apical lung mass presented with subacute shortness of breath. Comprehensive evaluation of the patient’s symptoms and findings, including infectious and oncologic evaluation, were performed. Infectious evaluation revealed positive acid-fast bacilli sputum cultures with Mycobacterium chimerea intracellulare. Biopsy of the mass revealed a Lambda restricted amyloidoma, which is usually seen in lymphoproliferative diseases and disorders. Bone marrow biopsy did not reveal any monoclonal cell lines or neoplasms. Abdominal fat pad biopsy was performed to rule out systemic amyloid and the results were negative. The diagnosis of isolated apical pulmonary amyloidoma was made. EBRT was performed over 12 fractions in 24 mGy, with improvement in the patient’s symptoms. The diagnosis of pulmonary amyloid necessitates comprehensive evaluation. There is no specific treatment for pulmonary amyloid; however, there has been success with surgical intervention, cytotoxic medications, and EBRT. Successful treatment of the amyloidoma is based on its anatomic location. We suggest EBRT in fractionated doses for optimal treatment of rare isolated apical pulmonary amyloidoma.
AB - Patient: Male, 68-year-old Final Diagnosis: Amyloidoma Symptoms: Shortness of breath linical Procedure: — Specialty: Pulmonology Objective: Background: Case Report: Conclusions: Rare disease Amyloidosis refers to an assortment of diseases characterized by the accumulation and deposition of misfolded proteins in the extracellular matrix of tissues and organs. It may present systemically, affecting multiple organs, or locally by affecting a single organ. When the lungs or mediastinal structures are involved, the term pulmonary amyloid is used. Sole pulmonary involvement with amyloid is extremely rare. There is no definitive treatment for this disease, but proposed treatment options include surgery, cytotoxic medications, and external beam radiation therapy (EBRT). A 68-year-old man with a left apical lung mass presented with subacute shortness of breath. Comprehensive evaluation of the patient’s symptoms and findings, including infectious and oncologic evaluation, were performed. Infectious evaluation revealed positive acid-fast bacilli sputum cultures with Mycobacterium chimerea intracellulare. Biopsy of the mass revealed a Lambda restricted amyloidoma, which is usually seen in lymphoproliferative diseases and disorders. Bone marrow biopsy did not reveal any monoclonal cell lines or neoplasms. Abdominal fat pad biopsy was performed to rule out systemic amyloid and the results were negative. The diagnosis of isolated apical pulmonary amyloidoma was made. EBRT was performed over 12 fractions in 24 mGy, with improvement in the patient’s symptoms. The diagnosis of pulmonary amyloid necessitates comprehensive evaluation. There is no specific treatment for pulmonary amyloid; however, there has been success with surgical intervention, cytotoxic medications, and EBRT. Successful treatment of the amyloidoma is based on its anatomic location. We suggest EBRT in fractionated doses for optimal treatment of rare isolated apical pulmonary amyloidoma.
KW - Amyloidosis
KW - Hematology
KW - Pulmonary Medicine
KW - Radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=85200828376&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85200828376&partnerID=8YFLogxK
U2 - 10.12659/AJCR.944582
DO - 10.12659/AJCR.944582
M3 - Article
C2 - 39107985
AN - SCOPUS:85200828376
SN - 1941-5923
VL - 25
JO - American Journal of Case Reports
JF - American Journal of Case Reports
M1 - e944582
ER -